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ALL the experiments carried out in various laboratories since the publicatioils
ofFoley (1953) and Prehn and Main (1957) concerning the antigenicity ofexperi-
mental tumours confirmed that sarcomas induced by carcinogenic hydrocarbons
contain specific antigens (Re've'sz, 1960; Klein et al., 1960; Koldovsk', 1961a; y
Old etal., 1961 ; Pasternak, Horn andGraffi, 1962a). This conclusion, forexample,
resulted from experiments in which resistance against cell inocula of the same
isologous tumour could beproducedbypretreatment ofmice withX-ray irradiated
tissue suspensions of a tumour or after ligation and following regression of a sub-
cutaneous or an intradermal tumour graft.
Since immunologic cross-reactions, even between tumours which were induced
by the same carcinogen, could not be observed by most ofthe investigators (Klein
et al., 1960; Prehn, 1961 ; Feldman, Globerson and Yaffee, 1962; Pasternak etal.,
1962b, in contrast to Koldovsk', 1961b) for each of these tumours, individually
specific antigens may be suggested.
A specific antigenicity could also be demonstrated for the tumours in mice
induced by the polyoma virus. In contrast to the carcinogen-induced tumours at
least a great number of those tumours in mice induced by this virus, seem to con-
tain the same cellular antigen (universal antigen) (Habel, 1961 ; Sj6gren, 1961),
since resistance against isologous tumour grafts developed both after treatment
of the animals with the virus and after homotransplantation of the polyoma
tumours. Virus-neutralizing antibodies did not affect the growth of the tumours.
These differences concerning the antigenic properties of tumours of different
aetiologysuggested aninvestigation oftheantigenicity ofvirus-inducedleukaemias.
The results ofearlierexperiments (Pasternak et al., 1962c) already indicated the
possibility of an active immunization at leastagainst one ofthe two transplantable
myeloid leukaemias of the strains C57BI and CBA tested. Furthermore, Klein,
Sj6gren and Klein (1962) were able to prove in extensive experiments that also in
mice a state of relative resistance may be produced against lymphomas, induced
by the Gross agent, if the recipients were pretreated with homografts of these
leukaemias or with sub-threshold cell doses of the sameisologous lymphoma. The
partial or complete cross-reactions obtained for the differentlymphomas, indicate
that similar or identical antigens may be found in these virus tumours which are
however different from those ofpolyoma tumours.
In the present paper the existence ofspecific antigens in isologous grafts of the
virus-induced myeloid leukaemia of mice (Graffi et al., 1954) will be described.533 INDUCTION OF RESISTANCE AGAINST LEUKAEMIAS
Since in previous experiments (Pasternak and Graffi, 1961) common antigenic
components in viruses of the myeloid and the lymphatic leukaemia could be
proved, we were especially interested in the antigenic relations between the
different types ofleukaemias induced by these viruses.
MATERIALS AND METHODS
Experimental animals and tumour donors were inbred mice ofthe strainsCBA,
C57BI, XVII andAKR. In one oftheexperimentsFl-hybridsproducedbycrossing
XVII females and CBA males were used. AR animals were taken from a breed
which is maintained by brother-to-sister mating (Pasternak and Gryschek, 1962).
The skin graftings performed showed the homogenicity of the strains used; the
survival of the grafts exceeded 150 days.
The leukaemias used for the experiments and their data arepresented in Table
1. All of the myeloid leukaemias were induced by injection of cell-free filtrates of
TABLE I.-Some Data on the Leukaemias usedfor the Experiments
Number of
transfer
Latency generations
period Strain of in isologous
Designation Induced by (days) origin hosts Histological type
PL 1462 Virus of mye- 161 CBA 46 Myeloid leukaemia
loid leukaemia
L 129/6d 158 C57BI 17
(Chloroleukaemia)
L 112b 206 C57BI 21 Myeloid leukaemia
L 184/3a 119 xvii 14
L 1205 Gross agent 303 AKR 2 Lyniphatic
(spontaneouslv leukaemia
developed)
L 1061 31 . 326 AKR
L 1937 311, 216 AKR
virus-induced leukaemias in newborn mice. These leukaemias were transplanted
to the original strain. In these experiments each of the leukaemias was tested in
different generations of transplanting, in order to determine possible changes in
the antigenic composition. The lymphatic leukaemias developed spontaneously
in mice of the AKR strain containing the Gross agent. Lymph nodes and spleens
from animals with leukaemias L 1061 and L 1937 weretransplanted for immuniza-
tion purposes exclusively to homologous recipients; in addition the leukaemia
L 1205 was further transplanted to isologous recipients.
In each of the transplantation or immunization experiments performed with
leukaemic materials the sex ofthe animals was taken into consideration to exclude
reactions against Y-linked H-antigens. Leukaemias however which originated
from females were also transplanted to males. All experimental animals were of
uniformweight ; their ageranging from 3 to 4 months. For purposes ofimmuniza-
tion the animals were treated as follows :
(1) At intervals of two weeks isologous recipients received 2 to 3 subcutaneous
injections of a suspension from leukaemic tissue (0-2 to 0-3 ml. each), which had
been irradiated in vitro at a dose of 14500 r. For that purpose the tissue (intra-
musculargraft, lymph nodes orspleens) was cut into smallpieces with scissors and534 G. PASTERNAK AND A. GRAFFI
slightly homogenized by hand in a small quantity of aphosphate-buffered isotoiiic
saline solution using a Potter glass homogenizer. Previous to irradiation the sus-
pensioii which contained for the most part intact cells aiid cell aggregates was
further diluted with a saline solution to a ratio of I : 4 as compared to the initial
weight of the material.
(2) Under similar experimental conditionshomologous recipients received sub-
cutaneous injections of the same but non-irradiated tissue suspension in doses of
0.2 to 0-3 ml. In general one single treatment was sufficient to produce resistailce
against isologous grafts ofmyeloid leukaemia.
(3) Isologous recipients were treated by subcutaneous injections of sub-
threshold cell doses (in some cases up to 5 X 104 cells). Only those animals were
taken for the tests which did not show any subcutaneous tumours or in which the
tumours regressed after temporary growth.
Testinjections for the determination ofthe induced resistance were made either
1-7 days after treatment with the irradiated tissue suspensions or at particular
intervals after the animals had been pretreated with sub-threshold cell doses. The
cell suspensions were obtainedbytrypsination (0- 15 per cent solution) ofthe tissue
material (Graffi, Pasternak and Horn, 1962). After vital staining with trypan blue
the cells were counted and adjusted to the doses required.
The animals were pretreated by left lateral subcutaneous injectioils while the
test injections were given subcutaneously on the right side. In some experimeilts
the intravenous mode of administration was chosen. The results of experiments
presented in the different tables include the number of resistant animals in com-
parison with the total number of test animals which were fit for evaluation.
RESULTS
Induction of resi,3tance against graft8 of viru8-induced inyeloid leukaemia-8 by pi-e-
treatment of mice with isoloyou8 tumour material
The results summarized in Table 11 indicate that 78-9 per cent of the pre-
treated animals are resistant to cell inocula of isologous leukaemias as compared
with 12-0 per cent of the untreated controls. This difference is statistically highly
significant and implies that the pretreatment gave rise to an active defence of the
host. The effect was marked in all three strains ofmice, on each ofwhich one type
of myeloid leukaemia was tested. It should be mentioned, however, that the
method emploved for immunization plays an essential role for producing this
resistance. After treatment of CBA niice with irradiated tissue of leukaemia PL
1462 it was at no time possible to demonstrate a resistance against grafts of this
isologous tumour, while mice ofthe strain XVII revealed a strong resistancehaving
received the same treatment with tissue material of leukaemia L 184/3a-both
after subcutaneous and intravenous test injections. That the leukaemia PL 1462
contains specific antigens and that CBA mice were able to react against this type
of leukaemia results from the fact that after pretreating the animals with sub-
threshold doses of cells, the number of takes in the test group was noticeably
diminished in comparison with those in the control group.
The results obtained after immunization of C57BI mice with tissue material
from the leukaemia L 129/6d indicate that an active resistance was produced by
using both methods of immunization. Detailed data on the varying effectiveness
of certain methods ofimmunization will bepublished later.INIDUCTION OF RESISTANCE AGAINST LEUKAEMIAS 01',35
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Induction of resistance against isologous grafts of virus-induced myeloid leukaemias
by pretreatment of mice, with homologous grafts of myeloid leukaemias (im-
munologic cross-experiments)
Inbred mice, in which homologous grafts of virus-induced myeloid leukaemias
have regressed, reveal a relative resistance to isologous grafts from leukaemias of
the same origin. This conclusion can be drawn from the results of experiments
presented in Table 111. In addition the table contains the results ofcross-experi-
ments carried out with leukaemias L 129/6d and L 112b on C57BI mice. C57BI
mice in which resistance wasproducedagainst cell inocula ofthe leukaemia L 129/
6d were also resistant toisologousgrafts ofthe leukaemia L 112b. The final results
of 63-7 per cent of resistant animals in the test group as compared with 33-3 per
cent in the control group is statistically highlysignificant.
Experiment-3 to produce resistance against isologous grafts of virus-induced myeloid
leukaemia8bypretreatmentofmice withhomologousgraftsofvirus-conditioned
lymphatic leukaemias
The three experiments hitherto performed utilized different lines of the lym-
phatic leukaemia for the pretreatment of mice of the strains XVII and C57BI.
They showed the progressive growth ofisologous grafts ofmyeloid leukaemias on
these animals. In comparison with the controls even a certaingrowth-stimulating
effect was found in mice subjected to treatment. While homologous grafts of
myeloid leukaemias induce an active resistance against cell inocula of isologous
leukaemiashavingthe sameorigin,homologousgraftsofspontaneous virus-induced
leukaemias of the AKR strain are not able to produce resistance against grafts of
myeloid leukaemias. The percentage of resistant animals in the test group was
1-9 as against 7-1 in the control group.
TABLIF, IV.-Results of the Experiments to Produce Resistance Against Isologous
Grafts of Virus-induced Myeloid Leukaemia8 by Pretreatment of Mice with
Homologous Grafts of Virus-conditioned Lymphatic Leukaemias
Line of
leukaemia (Genotype Designation of Number
Mouse strain used for of challenge of cells Immunized Control
inoculated pretreatment origin) leukaemia inoculated group group
xvii L 1205 (AKR) L 184/3a
5 X 104 0/19* 0/10*
C57BL L 1061 (AKR) L 129/6d 105 1/20 2/9
C57BL L 1937 (AKR) L 129/6d 3 x 10,5 0/13 0/9
Total : 1/52 2/28
Pereentage of resistant animals: 1,9 7,1
z2 1,5
p >0,3
Number of resistant animals over the total number inoculated.
DISCUSSION
The experiments performed indicate the possibility of producing resistance
against isologous grafts of virus-induced myeloid leukaemias by pretreatment of
mice with cells or tissues oftransplantable leukaemias of the same origin. Such a
resistance is ascertainable if about 104 to 105 cells are given subcutaneously or
intravenously; thepercentage ofresistant animals in the test group issignificantlyINDUCTION OF RESISTANCE AGAINST LEUKAEMIAS 537
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higher than in the group of the controls which had not beeii immunized. The
treatment of coiitrol animals with normal tissues was considered dispensable since
previous experiments (Pasternak et al., 1962a) had proved that the growth of
isologous tumour grafts was not influenced by this pretreatment.
Considering these results obtained with myeloid leukameias aiid the findings of
Kfein et al. (1962) resulting from work with lymphatic leukaemias and takilig into
coiisideration studies by Sachs (1962), it may be assumed that in geiieral virus-
induced leukaemias in mice reveal a specific antigenicity.
In the experiments of Sachs, who tested leukaemias induced by the Molonev
virus, a resistance against isologous grafts of these leukaemias was also produced
by pretreatment of mice with a virus-containing tissue culture fluid. This would
be inapproximate accordance with the effect observedby Habel (1961) andSj6gren
(1961) for the polyoma virus which showed that the growth of polyoma tumour
grafts is inhibited if adult mice had been pretreated with this virus. Klein et W.
(1962) were not able to detect cross-reactions between the leukaemias and the
polyoma tumours, a fact indicating the existence of different antigens. Yet, the
mode of induction of a new cellular antigen by the action of either a DNA-virus
or a RNA-virus seems to be most similar. The present results do not allow assump-
tions as to whether thespecificantigenicity is confinedexclusively to themalignant
cell. And, similarly, the role which viral antigens play in producing a resistance
to isologous grafts of leukaemias is not thoroughly clear. In a previous paper
(Pasternak and Graffi, 1961) we were able to show that the virus of myeloid
leukaemia is inactivated both by antisera against cell-free filtrates of myeloid
leukaemias and by similar antisera against lymphatic leukaemias (induced by the
Gross agent). These viruses seem to contain common antigens though the cellular
antigens of both types ofleukaemia are probably different as can be seen from the
absence of cross-reactions described for the present experiments. It remains to be
seen which antigenic correlations will be found to exist between other types of
leukaemias induced by different viruses and those already tested.
The absence of cross-reactions between virus-induced lymphatic leukaemias
and leukaemias of different aetiology (Slettenmark and Klein, 1962) is a proof of
theexceptionalposition virus-induced leukaemias occupy. Judgingfrom the results
hitherto available the existence of a universal antigen ofleukaemias appears to be
doubtful.
SUMMARY
Resistance against isotransplaiitation of virus-induced myeloid leukaemias of
mice was produced by pretreatment of the animals with irradiated tissue suspen-
sions of these leukaemias or by inocWation of small doses of viable cells prepared
from isologous leukaemic material or by homotransplantation of leukaemic tissue
of the same origin. Mice treated under equal experimental conditions with homo-
logous grafts of spontaneous lymphatic leukaemias of the AKR strain did not
develop any resistance against isotransplantation of myeloid leukaemias. The
conclusion drawn is that the cells of the two types of leukaemias contain different
antigens.
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